Wearable Ambulatory Monitoring Device Market Forecast to 2027

Description

Wearable Ambulatory Monitoring Device Market Analysis

Market Overview

A wearable ambulatory monitoring device monitor the patient’s heart rates and give patient data to healthcare providers through a wireless network. The important factors leading to the market growth are increasing occurrence of cardiac disorders, demand for ambulatory monitoring devices, and increased prevalence of wireless mobile cardiac monitoring devices and better diagnostics.

However, product recalls, complications linked to devices, and rising availability of counterfeit items are dangers to the growth of the industry. Increasing expenditures in R&D for development of technologically improved products gives an opportunity for the worldwide wearable ambulatory monitoring device market to flourish.

Segment Overview

The Wearable Ambulatory Monitoring Device market is segmented into two sections based on product type and geographical areas. The Global Wearable Ambulatory Monitoring Device Market has been segmented into Implantable Cardiac Monitor, Mobile Cardiac Telemetry Device, Holter Monitor, and Cardiac Event Monitor based on product type.

Regional Analysis

According to region, the market for wearable ambulatory monitoring devices has been segmented into the Americas, Asia-Pacific, Europe, and the Middle East & Africa. Throughout the estimate period, the Americas are anticipated to rule the global market for wearable ambulatory monitoring devices. North America and Latin America are subdivided further into the Americas.

The larger share is primarily due to the presence of significant manufacturers like General Electric Company, iRhythm Technologies, and Boston Scientific Corporation, among others, the rising prevalence of cardiovascular diseases, acquisitions, and the introduction of new products to capture a sizeable market share.

The second-largest market for wearable ambulatory monitoring devices is anticipated to be in Europe. The primary driver of the market’s expansion in this region is the rise in the incidence of heart illnesses. Due to the region’s expanding population, rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and rising disposable income, the Asia-Pacific wearable ambulatory monitoring device market is anticipated to grow at the quickest rate.

The Middle East and Africa had the smallest market share in 2020 due to their limited economic progress and extremely low income. The market in this region is anticipated to expand, nonetheless, as a result of higher disposable income, greater healthcare demands from citizens, and increased public awareness.

Major Players

Numerous international, regional, and local firms are present in the market for wearable ambulatory monitoring devices. Boston Scientific Corporation (US), ACS Diagnostics (US), General Electric Company (US), Hill-Rom Services Inc. (US), Asahi Kasei Corporation (Japan), Medtronic Plc (Ireland), Medicomp Inc. (US), G Medical Innovations (Israel), Koninklijke Philips NV (Netherlands), Asahi Kasei Corporation (Japan), Asahi Kasei Corporation (Japan), and iRhythm Technologies (US).

COVID 19 Impacts

COVID-19 has forced healthcare organizations to adapt their business models in order to operate effectively. The significance of R&D activities in the creation of wearable ambulatory monitoring systems has been brought to light by changing healthcare needs. The earliest stages saw lab closures and a halt to ongoing research.

Medical device researchers were prompted to stay at home by the constrained mobility constraints. During the first stage of the lockdown, this had a negative influence on the market. The people who need emergency heart surgical therapy, however, require constant surveillance, and the current cardiac patients require 24/7 monitoring. As a result, the government authorities permitted the research centers to run with a little staff.

 

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 HIGH PREVALENCE OF CARDIOVASCULAR DISEASES

4.2.2 INCREASING DEMAND FOR AMBULATORY MONITORING DEVICES

4.2.3 QUICK AND ENHANCED DIAGNOSIS OF CARDIOVASCULAR DISEASES

4.3 RESTRAINTS

4.3.1 PRODUCT RECALLS

4.3.2 COMPLICATIONS RELATED TO DEVICES

4.4 OPPORTUNITIES

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN AMBULATORY MONITORING DEVICES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION, MARKETING, & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 COVID-19 IMPACT ANALYSIS

5.3.1 IMPACT ON R&D

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON RAW MATERIAL

5.3.4 IMPACT ON DEMAND AND SUPPLY

5.4 INDEPENDENT DIAGNOSTIC TESTING FACILITY (IDTF) LIST

6 GLOBAL WEARABLE AMBULATORY MONITORING DEVICE MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 CARDIAC EVENT MONITOR

6.3 HOLTER MONITOR

6.4 MOBILE CARDIAC TELEMETRY DEVICE

6.5 IMPLANTABLE CARDIAC MONITOR

7 GLOBAL WEARABLE AMBULATORY MONITORING DEVICE MARKET, BY REGION

7.1 OVERVIEW

7.2 AMERICAS

7.2.1 NORTH AMERICA

7.2.1.1 US

7.2.1.2 CANADA

7.2.2 SOUTH AMERICA

7.3 EUROPE

7.3.1 WESTERN EUROPE

7.3.1.1 GERMANY

7.3.1.2 FRANCE

7.3.1.3 UK

7.3.1.4 ITALY

7.3.1.5 SPAIN

7.3.1.6 REST OF WESTERN EUROPE

7.3.2 EASTERN EUROPE

7.4 ASIA PACIFIC

7.4.1 JAPAN

7.4.2 CHINA

7.4.3 INDIA

7.4.4 AUSTRALIA

7.4.5 SOUTH KOREA

7.4.6 REST OF ASIA PACIFIC

7.5 MIDDLE EAST & AFRICA

7.5.1 MIDDLE EAST

7.5.2 AFRICA

8 COMPETITIVE LANDSCAPE

8.1 OVERVIEW

8.2 COMPETITIVE BENCHMARKING

8.3 MAJOR GROWTH STRATEGY IN THE GLOBAL WEARABLE AMBULATORY MONITORING DEVICE MARKET

8.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL WEARABLE AMBULATORY MONITORING DEVICE MARKET

8.5 KEY DEVELOPMENT ANALYSIS

8.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

8.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

8.6.2 ACQUISITION

8.6.3 COLLABORATION

8.6.4 PARTNERSHIP/AGREEMENT

8.7 MAJOR PLAYERS FINANCIAL MATRIX

8.7.1 SALES & OPERATING INCOME MARGIN (USD MILLION), 2020

8.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020

9 COMPANY PROFILES

9.1 GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

9.1.1 COMPANY OVERVIEW

9.1.2 FINANCIAL OVERVIEW

9.1.3 PRODUCTS/SERVICES OFFERED

9.1.4 KEY DEVELOPMENTS

9.1.5 SWOT ANALYSIS

9.1.6 KEY STRATEGIES

9.2 ACS DIAGNOSTICS, INC.

9.2.1 COMPANY OVERVIEW

9.2.2 FINANCIAL OVERVIEW

9.2.3 PRODUCTS/SERVICES OFFERED

9.2.4 KEY DEVELOPMENTS

9.2.5 SWOT ANALYSIS

9.2.6 KEY STRATEGIES

9.3 KONINKLIJKE PHILIPS N.V. (BIOTELEMETRY INC.)

9.3.1 COMPANY OVERVIEW

9.3.2 FINANCIAL OVERVIEW

9.3.3 PRODUCTS/SERVICES OFFERED

9.3.4 KEY DEVELOPMENTS

9.3.5 SWOT ANALYSIS

9.3.6 KEY STRATEGIES

9.4 IRHYTHM TECHNOLOGIES, INC.

9.4.1 COMPANY OVERVIEW

9.4.2 FINANCIAL OVERVIEW

9.4.3 PRODUCTS/SERVICES OFFERED

9.4.4 KEY DEVELOPMENTS

9.4.5 SWOT ANALYSIS

9.4.6 KEY STRATEGIES

9.5 MEDICOMP INC.

9.5.1 COMPANY OVERVIEW

9.5.2 FINANCIAL OVERVIEW

9.5.3 PRODUCTS/SERVICES OFFERED

9.5.4 KEY DEVELOPMENTS

9.5.5 SWOT ANALYSIS

9.5.6 KEY STRATEGIES

9.6 MEDTRONIC PLC.

9.6.1 COMPANY OVERVIEW

9.6.2 FINANCIAL OVERVIEW

9.6.3 PRODUCTS/SERVICES OFFERED

9.6.4 KEY DEVELOPMENTS

9.6.5 SWOT ANALYSIS

9.6.6 KEY STRATEGIES

9.7 BOSTON SCIENTIFIC CORPORATION (PREVENTICE SOLUTIONS, INC.)

9.7.1 COMPANY OVERVIEW

9.7.2 FINANCIAL OVERVIEW

9.7.3 PRODUCTS/SERVICES OFFERED

9.7.4 KEY DEVELOPMENTS

9.7.5 SWOT ANALYSIS

9.7.6 KEY STRATEGIES

9.8 G MEDICAL INNOVATIONS (TELERHYTHMICS, LLC)

9.8.1 COMPANY OVERVIEW

9.8.2 FINANCIAL OVERVIEW

9.8.3 PRODUCTS/SERVICES OFFERED

9.8.4 KEY DEVELOPMENTS

9.8.5 SWOT ANALYSIS

9.8.6 KEY STRATEGIES

9.9 HILL-ROM SERVICES INC.

9.9.1 COMPANY OVERVIEW

9.9.2 FINANCIAL OVERVIEW

9.9.3 PRODUCTS/SERVICES OFFERED

9.9.4 KEY DEVELOPMENTS

9.9.5 SWOT ANALYSIS

9.9.6 KEY STRATEGIES

9.10 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)

9.10.1 COMPANY OVERVIEW

9.10.2 FINANCIAL OVERVIEW

9.10.3 PRODUCTS/SERVICES OFFERED

9.10.4 KEY DEVELOPMENTS

9.10.5 SWOT ANALYSIS

9.10.6 KEY STRATEGIES

10 APPENDIX

10.1 REFERENCES

10.2 RELATED REPORTS